News

New research on how solid particles group together in the small intestine could aid our understanding of how nutrients and drug particles are absorbed during digestion.

Cardiff University researchers have uncovered new information about the underlying mechanisms for gastric cancer, providing hope of potential new therapies in the future.

Geneticists have created a new model-in-a-dish of sporadic Alzheimer’s disease, which accounts for more than 90 percent of Alzheimer’s cases and tends to strike people without a family history of the disease.

Researchers at the Rudolf Virchow Center of the University of Würzburg have unveiled the molecular effectiveness of artemisinins. The findings could lead to drugs for diseases such as Alzheimer's, schizophrenia and epilepsy.

An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.

Doctors made the world-first step by carrying out a clinical trial using stem cells from donors to create tissue that was transplanted into patients with a condition that causes blindness.

Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.

A team of researchers has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm, or arrhythmia, after experiencing a heart attack.

Researchers have been struggling for years to find a treatment for patients who have a recurrence of acute myeloid leukemia (AML), a team are now developing a series of drug compounds that have shown promise in treating such cases.

Two transcription factors have been identified which promote 'Dux' activation - a driver of mammalian genome development immediately after fertilization.